Agency
Crossroads Treatment Center of Northern Kentucky, PSC
Crossroads Treatment Center of Northern Kentucky, PSC was paid $4.80M by Medicaid between Aug 2018 and Dec 2024, across 21 billing codes. Its largest line is H0020, Alcohol and/or drug services; methadone administration and/or service (provision of the drug by a licensed program) — 78% of everything it billed.
33Billing provider infoCROSSROADS TREATMENT CENTER OF NORTHERN KENTUCKY, PSC
INDEPENDENCE, KY 41051
INDEPENDENCE, KY 41051
33aNPI1174040034assigned 08/23/2017
33bProvider typeCommunity/Behavioral Health Agency
28Total paid$4.80M
24GClaims166,705
24DCodes billed21
24AFirst – last monthAug 2018 – Dec 2024
Compared with peers
Next to other Community/Behavioral Health Agency providers in Kentucky
Rank by total paid#37 of 152
Median peer was paid$938K
This provider vs. median5.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official MCCORMAC, RUPERT controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 3,022 | $35K | |
| 2019 | 85,916 | $620K | |
| 2020 | 41,101 | $1.21M | |
| 2021 | 10,394 | $920K | |
| 2022 | 11,030 | $756K | |
| 2023 | 9,345 | $734K | |
| 2024incomplete | 5,897 | $531K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| H0020 | Alcohol and/or drug services; methadone administration and/or service (provision of the drug by a licensed program) | 78% | 66,538 | 11,110 | $3.76M |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 10% | 72,443 | 3,980 | $497K |
| T1007 | Alcohol and/or substance abuse services, treatment plan development and/or modification | 2.8% | 2,291 | 1,911 | $136K |
| 99408 | 2.7% | 15,178 | 1,143 | $130K | |
| H0016 | Alcohol and/or drug services; medical/somatic (medical intervention in ambulatory setting) | 2.1% | 570 | 533 | $100K |
| H0033 | Oral medication administration, direct observation | 1.5% | 1,025 | 787 | $73K |
| 90832 | Psychotherapy session, about 30 minutesPsychotherapy, 30 minutes with patient | <1% | 3,265 | 1,188 | $48K |
| 90853 | Group psychotherapy (other than of a multiple-family group) | <1% | 2,137 | 722 | $17K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | <1% | 372 | 315 | $15K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | <1% | 774 | 623 | $14K |
| 82075 | <1% | 850 | 735 | $7K | |
| 90791 | Psychiatric diagnostic evaluationPsychiatric diagnostic evaluation | <1% | 165 | 105 | $3K |
9 more codes
| 99441 | <1% | 481 | $2K | |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 89 | $1K |
| 99406 | <1% | 264 | $1K | |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | <1% | 67 | $469.77 |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 14 | $350.45 |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 66 | $186.42 |
| 80305 | <1% | 82 | $109.37 | |
| 86580 | <1% | 16 | $55.60 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 18 | $34.18 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMCCORMAC, RUPERT (CHIEF EXECUTIVE OFFICER)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.